到 2030 年口腔炎治疗市场预测：按类型、药物类别、剂型、适应症、给药途径、给药配销通路、最终用户和地区进行的全球分析

根据 Stratistics MRC 的数据，2023 年全球口腔炎治疗市场规模将达到 15.9 亿美元，预计 2030 年将达到 23.7 亿美元，预测期内复合年增长率为 5.9%。

口腔溃疡，通常称为溃疡，是出现在舌头、脸颊内侧和嘴唇上的令人难以忍受的溃疡。口腔溃疡通常会在 1 至 2 週内自行癒合，但有一些治疗方法可以减轻不适并加速癒合。含有苯佐卡因或水杨酸胆碱的非处方外用软膏或凝胶也可以缓解疼痛。用盐水漱口也可能有助于减少发炎和促进癒合。

根据世界卫生组织2020年报告，2020年全球约22.30%的人口消费烟草製品，全球80%以上的烟草使用者生活在低收入和中等收入国家。使用烟草会导致口腔溃疡，进而增加对治疗产品的需求。

增加知识和获得医疗保健的机会

在教育宣传活动和资讯普及的支持下，人们对口腔健康的认识不断提高，从而改变了对口腔健康问题（如口腔溃疡）及时就医的态度。在实体基础设施和远端医疗选择方面改善医疗保健服务的可近性，增加了快速解决口腔健康问题的可能性。

缺乏标准化治疗指南

口腔炎的治疗指引尚未标准化或广泛接受，增加了医疗治疗的变异性。不同的临床医生可能采取不同的方法，因此很难建立标准化的治疗方案。此外，标准化的缺乏使得该行业难以提供简洁且有科学支持的口腔溃疡治疗方案。

全面的牙齿健康成为日益重要的优先事项

随着人们越来越意识到口腔健康与整体健康之间的联繫，口腔溃疡治疗市场有机会在整体口腔清洁用品的大背景下立足。此外，将预防措施、饮食建议和生活方式提案纳入治疗计划可以利用这一趋势并促进更彻底的以患者为中心的方法。

经济衰退与经济承受能力问题

经济不稳定和景气衰退可能会影响消费者在医疗用品（例如口腔溃疡药物）上的金额。经济困难可能会导致人们选择更便宜的选择或推迟接受帮助。此外，市场参与企业将检查定价策略、患者援助计划和市场进入工作，以确保在经济不确定时期持续可及，从而减轻经济挑战的影响。您应该这样做。

COVID-19 的影响：

由于製造、供应链和医疗保健的中断，COVID-19 大大流行对口腔炎治疗市场产生了重大影响。由于封锁、社交距离措施以及与疫情相关的医疗保健优先事项增加，导致常规医疗就诊次数减少，口腔溃疡的诊断和治疗受到影响。此外，该市场的收益流也可能受到消费行为变化和影响购买模式的经济不确定性的影响。

预计抗生素市场在预测期内将是最大的市场

市场占有率最大的细分市场是抗菌剂细分市场。抗菌药物（例如局部抗生素和防腐剂）对于口腔溃疡的治疗至关重要，因为它们能够预防或治疗细菌和微生物感染。这些治疗方法因其集中治疗口腔溃疡的感染性方面、促进癒合和减少相关症状而经常被推广。此外，抗菌领域有多种局部製剂，如凝胶、软膏和漱口水，为医疗保健专业人员和消费者提供了多种有效治疗口腔溃疡的选择。

家庭护理产业预计在预测期内复合年增长率最高

在口腔炎治疗市场中，家庭护理领域的复合年增长率最高。这一增长的推动因素包括在家中使用非处方口腔溃疡药物的便利性、自行用药的日益普及以及支持远距咨询的远端医疗服务的发展。此外，口腔保健意识的提高和技术进步使人们无需等待紧急临床干预即可获得治疗口腔炎的资讯和产品，这是向居家照护转变的主要驱动力。这是一个促成因素。

比例最高的地区：

在口腔炎治疗市场中，亚太地区占最大的市场占有率。许多因素促成了该地区的这一优势，包括口腔溃疡的高发病率、高龄化、口腔卫生意识的提高以及製药公司为扩大在新兴市场的足迹而做出的不懈努力。此外，亚太地区多样化的医疗保健格局、可支配收入的增加以及医疗基础设施的改善也促进了口腔炎治疗市场的强劲成长。

复合年增长率最高的地区：

在口腔炎治疗市场中，北美目前显示出最高的复合年增长率。强大的医疗基础设施、高昂的医疗成本以及对研发的重视正在推动该地区的强劲成长。该地区的高龄化、口腔溃疡发生频率的增加以及口腔健康意识的提高，都推动了对尖端、高效治疗方案的需求不断增长。此外，由于行业巨头的存在、技术进步和积极主动的医疗保健管理方法，北美市场正在扩大。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场公司的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

• 概述
• 相关利益者
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第三章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 最终用户分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代品的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第五章全球口腔炎治疗市场：依类型

• 次要的
• 选拔科目
• 疱疹性的
• 其他类型

第六章全球口腔炎治疗市场：依药物类别

• 抗菌的
• 抗组织胺药
• 止痛药
• 皮质类固醇
• 其他药物类别

第七章全球口腔炎治疗市场：按剂型

• 喷
• 漱口水
• 凝胶
• 菱形
• 其他剂型

第八章全球口腔炎治疗市场：依适应症分类

• 口疮性口炎
• 口腔扁平苔癣
• 其他适应症

第九章全球口腔炎治疗市场：依给药途径

• 口服
• 局部的

第十章全球口腔炎治疗市场：依配销通路

• 医院药房
• 零售药房
• 网路药房

第十一章全球口腔炎治疗市场：依最终使用者分类

• 居家护理
• 诊所
• 医院
• 其他最终用户

第十二章全球口腔炎治疗市场：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东/非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东/非洲

第十三章 主要进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第十四章 公司简介

• Celgene Corporation
• 3M Company
• GSK plc
• Colgate-Palmolive Company
• Blairex Laboratories, Inc.
• Dr. Reddy's Laboratories
• Dental Herb Company
• Bristol-Myers Squibb Company
• GlaxoSmithKline, Plc
• Patterson Companies, Inc.
• Pfizer, Inc.
• Akorn Pharmaceuticals
• Church & Dwight Co, Inc.
• Prince Care Pharma Private Limited
• Blistex Inc.
• Sun Pharmaceutical Jsc

According to Stratistics MRC, the Global Mouth Ulcer Treatment Market is accounted for $1.59 billion in 2023 and is expected to reach $2.37 billion by 2030 growing at a CAGR of 5.9% during the forecast period. Mouth ulcers, commonly referred to as canker sores, are excruciating sores that may appear on the tongue, inside the cheeks, or on the lips. Although they usually go away on their own in a week or two, there are treatments that can help reduce discomfort and encourage quicker healing. Moreover, benzocaine or choline salicylate-containing over-the-counter topical ointments or gels can relieve pain. It might also be beneficial to rinse the mouth with a saltwater solution to lessen inflammation and encourage healing.

According to WHO 2020 report, in 2020, approximately 22.30% of the global population consumed tobacco products, and over 80% of the world's tobacco users live in low- and middle-income countries. Tobacco use can lead to mouth ulcers and thus the demand for treatment products increases.

Market Dynamics:

Driver:

Increasing knowledge and access to healthcare

An attitude shift toward seeking prompt medical attention for oral health issues, such as mouth ulcers, has resulted from increased awareness of oral health, which has been supported by educational campaigns and information dissemination. Individuals are more likely to address oral health concerns promptly when there is improved access to healthcare services, both in terms of physical infrastructure and telehealth options.

Restraint:

Absence of standardized guidelines for treatment

The lack of standardized and widely accepted treatment guidelines for mouth ulcers adds to the variation in medical procedures. Different approaches may be taken by clinicians, which make it difficult to establish standardized treatment protocols. Furthermore, this lack of standardization may make it more difficult for the industry to offer concise, scientifically supported mouth ulcer treatment options.

Opportunity:

Growing priority for comprehensive dental health

The market for mouth ulcer treatments has a chance to establish itself within the larger context of holistic oral care as people become more conscious of the link between oral health and general well-being. Moreover, preventive measures, dietary advice, and lifestyle suggestions can be incorporated into treatment plans to take advantage of this trend and promote a more thorough and patient-centered approach.

Threat:

Economic downturn and problems with affordability

Financial instability and economic downturns can affect how much consumers spend on medical supplies, such as mouth ulcer remedies. Financial difficulties can lead people to choose less expensive options or put off getting help. Additionally, market participants should investigate pricing strategies, patient assistance programs, and market access initiatives to ensure continued accessibility during times of economic instability in order to lessen the impact of economic challenges.

COVID-19 Impact:

Due to disruptions in manufacturing, supply chains, and healthcare access, the COVID-19 pandemic has had a major effect on the market for mouth ulcer treatments. The diagnosis and treatment of mouth ulcers have been impacted by the decline in routine healthcare visits brought on by lockdowns, social distancing measures, and the increased healthcare priorities associated with the pandemic. Furthermore, the market's revenue streams may also be impacted by changes in consumer behaviour and economic uncertainty, which have an impact on buying patterns.

The Antimicrobial segment is expected to be the largest during the forecast period

The segment with the largest market share is the antimicrobial segment, due to their ability to prevent or treat bacterial and microbial infections, antimicrobial agents-such as topical antibiotics and antiseptics-are essential in the management of mouth ulcers. Due to their focused approach to treating the infectious aspect of mouth ulcers, accelerating healing, and reducing related symptoms, these treatments are frequently encouraged. Moreover, healthcare practitioners and consumers have a variety of options for effectively managing mouth ulcers thanks to the antimicrobial segment's wide range of topical formulations, which include gels, ointments, and mouthwashes.

The Homecare segment is expected to have the highest CAGR during the forecast period

In the mouth ulcer treatment market, the homecare segment is growing at the highest CAGR. The convenience of using over-the-counter mouth ulcer treatments at home, the growing popularity of self-administered treatments, and the development of telehealth services that enable remote consultations are some of the factors contributing to this growth. Additionally, growing awareness of oral health management and technological advancements that make it possible for people to obtain information and products for treating mouth ulcers without waiting for urgent clinical intervention are the main drivers of the shift towards homecare.

Region with largest share:

In the mouth ulcer treatment market, the Asia-Pacific area holds the largest market share. Numerous factors contribute to this dominance, such as the high frequency of mouth ulcers in the area, an aging population, rising oral health awareness, and pharmaceutical companies' persistent efforts to increase their footprint in emerging markets. Furthermore, the diverse healthcare landscape of the Asia-Pacific region, along with rising disposable incomes and improved healthcare infrastructure, has also contributed to the market's robust growth for mouth ulcer treatments.

Region with highest CAGR:

In the mouth ulcer treatment market, North America is currently showing the highest CAGR. A strong healthcare infrastructure, high healthcare spending, and a strong emphasis on research and development are some of the factors driving the region's robust growth. The aging population in the area, the increasing frequency of mouth ulcers, and the increased focus on oral health all add to the rising need for cutting-edge and efficient treatment options. Moreover, the market is expanding in North America due in part to the presence of major players in the industry, technological advancements, and a proactive approach to healthcare management.

Key players in the market:

Some of the key players in Mouth Ulcer Treatment market include Celgene Corporation, 3M Company, GSK plc, Colgate-Palmolive Company, Blairex Laboratories, Inc., Dr. Reddy's Laboratories, Dental Herb Company, Bristol-Myers Squibb Company, GlaxoSmithKline, Plc, Patterson Companies, Inc., Pfizer, Inc., Akorn Pharmaceuticals, Church & Dwight Co, Inc., Prince Care Pharma Private Limited, Blistex Inc. and Sun Pharmaceutical Jsc.

Key Developments:

In December 2023, Dr Reddy's Laboratories on Wednesday said its unit has inked a licensing agreement with Coya Therapeutics Inc to develop a combination therapy for the treatment of amyotrophic lateral sclerosis (ALS). Dr Reddy's Laboratories SA and Coya have entered into a development and license agreement for the development and commercialisation of COYA 302, an investigational combination therapy for ALS, the Hyderabad-based drugmaker said in a statement.

In November 2023, GSK plc and Arrowhead Pharmaceuticals Inc. have announced that they have reached an agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to transfer exclusive worldwide rights to further develop and commercialise JNJ-3989 to GSK. JNJ-3989 (formerly ARO-HBV) was initially in-licensed by Janssen from Arrowhead in 2018.

In May 2023, 3M announced it has entered into agreements to sell certain assets associated with its dental local anesthetic portfolio, based in Seefeld, Germany, to Pierrel S.p.A. ("Pierrel"), a global provider of services for the pharmaceutical industry, for a purchase price of $70 million, subject to closing and other adjustments.

Types Covered:

• Minor
• Major
• Herpetiform
• Other Types

Drug Classes Covered:

• Antimicrobial
• Antihistamine
• Analgesics
• Corticosteroids
• Other Drug Classes

Formulations Covered:

• Sprays
• Mouthwash
• Gels
• Lozenges
• Other Formulations

Indications Covered:

• Aphthous Stomatitis
• Oral Lichen Planus
• Other Indications

Route of Administrations Covered:

• Oral
• Topical

Distribution Channels Covered:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

End Users Covered:

• Homecare
• Clinic
• Hospital
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Mouth Ulcer Treatment Market, By Type

• 5.1 Introduction
• 5.2 Minor
• 5.3 Major
• 5.4 Herpetiform
• 5.5 Other Types

6 Global Mouth Ulcer Treatment Market, By Drug Class

• 6.1 Introduction
• 6.2 Antimicrobial
• 6.3 Antihistamine
• 6.4 Analgesics
• 6.5 Corticosteroids
• 6.6 Other Drug Classes

7 Global Mouth Ulcer Treatment Market, By Formulation

• 7.1 Introduction
• 7.2 Sprays
• 7.3 Mouthwash
• 7.4 Gels
• 7.5 Lozenges
• 7.6 Other Formulations

8 Global Mouth Ulcer Treatment Market, By Indication

• 8.1 Introduction
• 8.2 Aphthous Stomatitis
• 8.3 Oral Lichen Planus
• 8.4 Other Indications

9 Global Mouth Ulcer Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Topical

10 Global Mouth Ulcer Treatment Market, By Distribution Channel

• 10.1 Introduction
• 10.2 Hospital Pharmacy
• 10.3 Retail Pharmacy
• 10.4 Online Pharmacy

11 Global Mouth Ulcer Treatment Market, By End User

• 11.1 Introduction
• 11.2 Homecare
• 11.3 Clinic
• 11.4 Hospital
• 11.5 Other End Users

12 Global Mouth Ulcer Treatment Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 Celgene Corporation
• 14.2 3M Company
• 14.3 GSK plc
• 14.4 Colgate-Palmolive Company
• 14.5 Blairex Laboratories, Inc.
• 14.6 Dr. Reddy's Laboratories
• 14.7 Dental Herb Company
• 14.8 Bristol-Myers Squibb Company
• 14.9 GlaxoSmithKline, Plc
• 14.10 Patterson Companies, Inc.
• 14.11 Pfizer, Inc.
• 14.12 Akorn Pharmaceuticals
• 14.13 Church & Dwight Co, Inc.
• 14.14 Prince Care Pharma Private Limited
• 14.15 Blistex Inc.
• 14.16 Sun Pharmaceutical Jsc

List of Tables

• Table 1 Global Mouth Ulcer Treatment Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Mouth Ulcer Treatment Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Mouth Ulcer Treatment Market Outlook, By Minor (2021-2030) ($MN)
• Table 4 Global Mouth Ulcer Treatment Market Outlook, By Major (2021-2030) ($MN)
• Table 5 Global Mouth Ulcer Treatment Market Outlook, By Herpetiform (2021-2030) ($MN)
• Table 6 Global Mouth Ulcer Treatment Market Outlook, By Other Types (2021-2030) ($MN)
• Table 7 Global Mouth Ulcer Treatment Market Outlook, By Drug Class (2021-2030) ($MN)
• Table 8 Global Mouth Ulcer Treatment Market Outlook, By Antimicrobial (2021-2030) ($MN)
• Table 9 Global Mouth Ulcer Treatment Market Outlook, By Antihistamine (2021-2030) ($MN)
• Table 10 Global Mouth Ulcer Treatment Market Outlook, By Analgesics (2021-2030) ($MN)
• Table 11 Global Mouth Ulcer Treatment Market Outlook, By Corticosteroids (2021-2030) ($MN)
• Table 12 Global Mouth Ulcer Treatment Market Outlook, By Other Drug Classes (2021-2030) ($MN)
• Table 13 Global Mouth Ulcer Treatment Market Outlook, By Formulation (2021-2030) ($MN)
• Table 14 Global Mouth Ulcer Treatment Market Outlook, By Sprays (2021-2030) ($MN)
• Table 15 Global Mouth Ulcer Treatment Market Outlook, By Mouthwash (2021-2030) ($MN)
• Table 16 Global Mouth Ulcer Treatment Market Outlook, By Gels (2021-2030) ($MN)
• Table 17 Global Mouth Ulcer Treatment Market Outlook, By Lozenges (2021-2030) ($MN)
• Table 18 Global Mouth Ulcer Treatment Market Outlook, By Other Formulations (2021-2030) ($MN)
• Table 19 Global Mouth Ulcer Treatment Market Outlook, By Indication (2021-2030) ($MN)
• Table 20 Global Mouth Ulcer Treatment Market Outlook, By Aphthous Stomatitis (2021-2030) ($MN)
• Table 21 Global Mouth Ulcer Treatment Market Outlook, By Oral Lichen Planus (2021-2030) ($MN)
• Table 22 Global Mouth Ulcer Treatment Market Outlook, By Other Indications (2021-2030) ($MN)
• Table 23 Global Mouth Ulcer Treatment Market Outlook, By Route of Administration (2021-2030) ($MN)
• Table 24 Global Mouth Ulcer Treatment Market Outlook, By Oral (2021-2030) ($MN)
• Table 25 Global Mouth Ulcer Treatment Market Outlook, By Topical (2021-2030) ($MN)
• Table 26 Global Mouth Ulcer Treatment Market Outlook, By Distribution Channel (2021-2030) ($MN)
• Table 27 Global Mouth Ulcer Treatment Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
• Table 28 Global Mouth Ulcer Treatment Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
• Table 29 Global Mouth Ulcer Treatment Market Outlook, By Online Pharmacy (2021-2030) ($MN)
• Table 30 Global Mouth Ulcer Treatment Market Outlook, By End User (2021-2030) ($MN)
• Table 31 Global Mouth Ulcer Treatment Market Outlook, By Homecare (2021-2030) ($MN)
• Table 32 Global Mouth Ulcer Treatment Market Outlook, By Clinic (2021-2030) ($MN)
• Table 33 Global Mouth Ulcer Treatment Market Outlook, By Hospital (2021-2030) ($MN)
• Table 34 Global Mouth Ulcer Treatment Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.